¹ Granted patent FR3136172.
² Ex-vivo test on Rosapeptide-3™.
³ Patent filed FR2508514.
⁴ Instrumental test on ingredient on 29 women on the average length of crow's feet wrinkles vs placebo.
⁵ Clinically proven on wrinkles, density, smoothing effect, lifting effect, firmness, elasticity, radiance, replenished appearance, reshaped contours, refined skin texture.
⁶ Clinical assessment on 30 women by a dermatologist after 2 months.
⁷ Clinical assessment on 30 women by a dermatologist on the evolution of the La Crème texture essentielle performance. Comparison between application at 8 hours and after 2 months.
⁸ Instrumental test on 30 women after 2 months of use of La Crème texture essentielle.
⁹ Clinical assessment on 30 women by a dermatologist on the evolution of product performance. Comparison between application at 1 week and after 2 months.
10 Concentration of rose complex in this formula vs. the previous version of Rosapeptide.
¹¹ Ex-vivo test on ingredients vs. ingredients of the previous complex.
¹² Ex-vivo test on Rosapeptide-3™ and its ingredients.
¹³ At Dior.
¹⁴ Clinical assessment by a dermatologist on 30 women. Comparison between the performance of La Crème after 4 weeks vs. La Crème + La Micro-Huile de Rose after 8 days on replenished appearance, wrinkles, firmness and loosened contours.